|
1
|
Xu S and Liu P: Tanshinone II-A: new
perspectives for old remedies. Expert Opin Ther Pat. 23:149–153.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tian XH and Wu JH: Tanshinone derivatives:
a patent review (January 2006 - September 2012). Expert Opin Ther
Pat. 23:19–29. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hur JM, Shim JS, Jung HJ and Kwon HJ:
Cryptotanshinone but not tanshinone IIA inhibits angiogenesis in
vitro. Exp Mol Med. 37:133–137. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lee CY, Sher HF, Chen HW, et al:
Anticancer effects of tanshinone I in human non-small cell lung
cancer. Mol Cancer Ther. 7:3527–3538. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang X, Wei Y, Yuan S, et al: Potential
anticancer activity of tanshinone IIA against human breast cancer.
Int J Cancer. 116:799–807. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lu Q, Zhang P, Zhang X and Chen J:
Experimental study of the anticancer mechanism of tanshinone IIA
against human breast cancer. Int J Mol Med. 24:773–780.
2009.PubMed/NCBI
|
|
7
|
Su CC, Chien SY, Kuo SJ, Chen YL, Cheng CY
and Chen DR: Tanshinone IIA inhibits human breast cancer MDA-MB-231
cells by decreasing LC3-II, Erb-B2 and NF-κBp65. Mol Med Rep.
5:1019–1022. 2012.PubMed/NCBI
|
|
8
|
Wang J, Wang X, Jiang S, et al: Growth
inhibition and induction of apoptosis and differentiation of
tanshinone IIA in human glioma cells. J Neurooncol. 82:11–21. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chiu TL and Su CC: Tanshinone IIA induces
apoptosis in human lung cancer A549 cells through the induction of
reactive oxygen species and decreasing the mitochondrial membrane
potential. Int J Mol Med. 25:231–236. 2010.PubMed/NCBI
|
|
10
|
Cheng CY and Su CC: Tanshinone IIA may
inhibit the growth of small cell lung cancer H146 cells by
upregulating the Bax/Bcl-2 ratio and decreasing mitochondrial
membrane potential. Mol Med Rep. 3:645–650. 2010.PubMed/NCBI
|
|
11
|
Jiao JW and Wen F: Tanshinone IIA acts via
p38 MAPK to induce apoptosis and the downregulation of ERCC1 and
lung-resistance protein in cisplatin-resistant ovarian cancer
cells. Oncol Rep. 25:781–788. 2011.PubMed/NCBI
|
|
12
|
Chen J, Shi DY, Liu SL and Zhong L:
Tanshinone IIA induces growth inhibition and apoptosis in gastric
cancer in vitro and in vivo. Oncol Rep. 27:523–528.
2012.PubMed/NCBI
|
|
13
|
Dai ZK, Qin JK, Huang JE, et al:
Tanshinone IIA activates calcium-dependent apoptosis signaling
pathway in human hepatoma cells. J Nat Med. 66:192–201. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu C, Li J, Wang L, et al: Analysis of
tanshinone IIA induced cellular apoptosis in leukemia cells by
genome-wide expression profiling. BMC Complement Altern Med.
12:52012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Won SH, Lee HJ, Jeong SJ, Lu J and Kim SH:
Activation of p53 signaling and inhibition of androgen receptor
mediate tanshinone IIA induced G1 arrest in LNCaP prostate cancer
cells. Phytother Res. 26:669–674. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wei X, Zhou L, Hu L and Huang Y:
Tanshinone IIA arrests cell cycle and induces apoptosis in 786-O
human renal cell carcinoma cells. Oncol Lett. 3:1144–1148.
2012.PubMed/NCBI
|
|
17
|
Pan TL, Wang PW, Hung YC, Huang CH and Rau
KM: Proteomic analysis reveals tanshinone IIA enhances apoptosis of
advanced cervix carcinoma CaSki cells through mitochondria
intrinsic and endoplasmic reticulum stress pathways. Proteomics.
13:3411–3423. 2013. View Article : Google Scholar
|
|
18
|
Liu M, Wang Q, Liu F, et al:
UDP-glucuronosyltransferase 1A compromises intracellular
accumulation and anti-cancer effect of tanshinone IIA in human
colon cancer cells. PLoS One. 8:e791722013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
20
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar
|
|
21
|
Novello S, Milella M, Tiseo M, et al:
Maintenance therapy in NSCLC: why? To whom? Which agent? J Exp Clin
Cancer Res. 30:502011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wu CP, Ohnuma S and Ambudkar SV:
Discovering natural product modulators to overcome multidrug
resistance in cancer chemotherapy. Curr Pharm Biotechnol.
12:609–620. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Giard DJ, Aaronson SA, Todaro GJ, et al:
In vitro cultivation of human tumors: establishment of cell lines
derived from a series of solid tumors. J Natl Cancer Inst.
51:1417–1423. 1973.PubMed/NCBI
|
|
24
|
Liu F, Yu G, Wang G, et al: An
NQO1-initiated and p53-independent apoptotic pathway determines the
anti-tumor effect of tanshinone IIA against non-small cell lung
cancer. PLoS One. 7:e421382012. View Article : Google Scholar
|
|
25
|
Danial NN and Korsmeyer SJ: Cell death:
critical control points. Cell. 116:205–219. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Green DR and Reed JC: Mitochondria and
apoptosis. Science. 281:1309–1312. 1998. View Article : Google Scholar
|
|
27
|
Davis RJ: Signal transduction by the JNK
group of MAP kinases. Cell. 103:239–252. 2000. View Article : Google Scholar
|
|
28
|
Wen M, Wang H, Zhang X, et al:
Cytokine-like 1 is involved in the growth and metastasis of
neuroblastoma cells. Int J Oncol. 41:1419–1424. 2012.PubMed/NCBI
|
|
29
|
Devignat R: Calculation of Reed and
Muench’s 50 percent point in survival time measured in a recording
cage. Ann Inst Pasteur (Paris). 83:372–380. 1952.
|
|
30
|
Franken NA, Rodermond HM, Stap J, et al:
Clonogenic assay of cells in vitro. Nat Protoc. 1:2315–2319. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Huang CC, Aronstam RS, Chen DR and Huang
YW: Oxidative stress, calcium homeostasis, and altered gene
expression in human lung epithelial cells exposed to ZnO
nanoparticles. Toxicol In Vitro. 24:45–55. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xu F, Yu H, Liu J and Cheng L:
Pyrroloquinoline quinone inhibits oxygen/glucose
deprivation-induced apoptosis by activating the PI3K/AKT pathway in
cardiomyocytes. Mol Cell Biochem. 386:107–115. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhao J, Chen X, Lin W, et al: Total
alkaloids of Rubus aleaefolius Poir inhibit hepatocellular
carcinoma growth in vivo and in vitro via activation
of mitochondrial-dependent apoptosis. Int J Oncol. 42:971–978.
2013.
|
|
34
|
Gao LW, Zhang J, Yang WH, Wang B and Wang
JW: Glaucocalyxin A induces apoptosis in human leukemia HL-60 cells
through mitochondria-mediated death pathway. Toxicol In Vitro.
25:51–63. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang Z, Wang S, Qiu H, Duan C, Ding K and
Wang Z: Waltonitone induces human hepatocellular carcinoma cells
apoptosis in vitro and in vivo. Cancer Lett. 286:223–231. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Viedma-Rodriguez R, Baiza-Gutman LA,
Garcia-Carranca A, Moreno-Fierros L, Salamanca-Gomez F and
Arenas-Aranda D: Suppression of the death gene BIK is a critical
factor for resistance to tamoxifen in MCF-7 breast cancer cells.
Int J Oncol. 43:1777–1786. 2013.
|
|
37
|
Zhao D, Lin F, Wu X, et al: Pseudolaric
acid B induces apoptosis via proteasome-mediated Bcl-2 degradation
in hormone-refractory prostate cancer DU145 cells. Toxicol In
Vitro. 26:595–602. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chipuk JE, Bouchier-Hayes L and Green DR:
Mitochondrial outer membrane permeabilization during apoptosis: the
innocent bystander scenario. Cell Death Differ. 13:1396–1402. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Newmeyer DD and Ferguson-Miller S:
Mitochondria: releasing power for life and unleashing the
machineries of death. Cell. 112:481–490. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Finucane DM, Bossy-Wetzel E, Waterhouse
NJ, Cotter TG and Green DR: Bax-induced caspase activation and
apoptosis via cytochrome c release from mitochondria is inhibitable
by Bcl-xL. J Biol Chem. 274:2225–2233. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Budihardjo I, Oliver H, Lutter M, et al:
Biochemical pathways of caspase activation during apoptosis. Annu
Rev Cell Dev Biol. 15:269–290. 1999. View Article : Google Scholar
|
|
42
|
Tournier C, Hess P, Yang DD, et al:
Requirement of JNK for stress-induced activation of the cytochrome
c-mediated death pathway. Science. 288:870–874. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Dong Y, Morris-Natschke SL and Lee KH:
Biosynthesis, total syntheses, and antitumor activity of
tanshinones and their analogs as potential therapeutic agents. Nat
Prod Rep. 28:529–542. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Tillhon M, Guaman Ortiz LM, Lombardi P and
Scovassi AI: Berberine: new perspectives for old remedies. Biochem
Pharmacol. 84:1260–1267. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Tsuruta F, Sunayama J, Mori Y, et al: JNK
promotes Bax translocation to mitochondria through phosphorylation
of 14–3-3 proteins. EMBO J. 23:1889–1899. 2004.PubMed/NCBI
|
|
46
|
Lei K, Nimnual A, Zong WX, et al: The Bax
subfamily of Bcl2-related proteins is essential for apoptotic
signal transduction by c-Jun NH(2)-terminal kinase. Mol Cell Biol.
22:4929–4942. 2002. View Article : Google Scholar
|
|
47
|
Bi HC, Zuo Z, Chen X, et al: Preclinical
factors affecting the pharmacokinetic behaviour of tanshinone IIA,
an investigational new drug isolated from Salvia
miltiorrhiza for the treatment of ischaemic heart diseases.
Xenobiotica. 38:185–222. 2008. View Article : Google Scholar : PubMed/NCBI
|
